FibroBiologics CSO buys $0.5 million in stock in private placement
Chief Scientific Officer Hamid Khoja purchased shares and warrants at market price, closing September 15, 2026.
SEC filing (2)
Latest
4 stories
Friday, September 18
Tuesday, September 15
FibroBiologics raises $0.5 million from CSO Hamid Khoja in private placement
The Houston biotech sold stock and warrants to its Chief Scientific Officer at $1.675 per unit, expecting to close the deal the same day.
SEC filing
Monday, August 24
FibroBiologics adds sports agent Leigh Steinberg to board of directors
The Houston biotech named the longtime athlete representative and brain health advocate a Class II director effective August 20, 2026.
SEC filing
Thursday, July 9
FibroBiologics adds retired NASA astronaut Kate Rubins to board of directors
The Houston biotech named Kathleen Rubins, Ph.D. a Class III director effective July 8, 2026, following Matt Link's resignation from the board.
SEC filing